Mayne Pharma and PLIVA Enter Strategic Biogeneric Partnership for EPO and G-CSF
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 58 (Table of Contents)
Published: 5 Apr-2005
DOI: 10.3833/pdr.v2005.i58.703 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Mayne Pharma and PLIVA formed a strategic alliance to co-develop two major anticancer products – erythropoietin and granulocyte colony stimulating factor...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS